Roche pleads for global harmony as it supercharges production of Actemra, COVID-19 tests
Tuesday, March 24, 2020
China’s use of Roche's Actemra for some COVID-19 patients has put the arthritis drug in the spotlight and set it up for a surge in demand. Roche is trying to stay ahead of that curve by upping production, even as it tests it on COVID-19
No comments:
Post a Comment